Professor Osagie K. Obasogie’s ‘Legacies of Eugenics’ Project
By Gwyneth Shaw,
Berkeley Law
| 08. 23. 2024
In this episode, host Gwyneth Shaw talks to Professor Osagie K. Obasogie, a professor of law and bioethics and the only UC Berkeley faculty member to hold an appointment at both our law school and our School of Public Health(opens in a new tab), including the Joint Medical Program(opens in a new tab) with UC San Francisco. As a sociologist of law and medicine, Obasogie’s research combines doctrinal scholarship with empirical methods and novel theoretical approaches to understand the ways race is central to how the institutions of law and medicine operate.
He’s the author of Blinded By Sight: Seeing Race Through the Eyes of the Blind and co-editor of Beyond Bioethics: Toward a New Biopolitics, and his scholarship has been published in top law reviews as well as major medical and science journals. Obasogie is an elected member of the National Academy of Medicine and won a Guggenheim Fellowship in 2022.
Recently, he organized and wrote the opening essay for a major project published in the Los Angeles Review of Books, “Legacies of Eugenics...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
By Emily Mullin, Wired | 10.30.2025
In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to make them immune to HIV and...